Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clene Inc. - Common Stock (NQ:CLNN)

5.970 +0.380 (+6.80%)
Streaming Delayed Price Updated: 10:08 AM EDT, Sep 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Clene Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Research Uncovers Possible Way to Repair Myelin in MS Patients
Via Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at H.C. Wainwright Global Investment Conference
Via Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Builds Late-Stage Momentum in Neuro Pipeline
Via Investor Brand Network
Pioneering Therapy Could Slow the Effects of Aging
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results as Company Prepares for NDA Submission and Extends Runway into 2026
Via Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results, Targets Year-End NDA Submission for ALS Therapy
Via Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present Corporate Update at Emerging Growth Conference on Aug. 20
Via Investor Brand Network
Parkinson’s-Gut Bacteria Link Suggests Surprisingly Simple Treatment Option
Via Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) to Present at Canaccord 45th Annual Growth Conference
Via Investor Brand Network
New AI-Based Speech Tool Detects Possibility of Parkinson’s Disease
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Offers Investors a Compelling Entry into the Growing ALS Market with Key FDA Milestones for Lead Drug Candidate
Via Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients
Via Investor Brand Network
Individuals Who Develop Multiple Sclerosis Have More Doctor Visits Decades Before Their Diagnosis
Via Investor Brand Network
Preclinical Study Finds a Way to Reverse Symptoms of Parkinson’s in Mice
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025
Via Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
Via Investor Brand Network
Why Public Interest in Mitochondrial Function Testing is Growing
Via Investor Brand Network
Q2 Virtual Investor Summit: Presentations Available Now
Via ACCESS Newswire
Study Finds Kids with MS Biologically Age Faster Than Those Without It
Via Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Rob Etherington to Present at June 10 Investor Summit Virtual
Via Investor Brand Network
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025
Via ACCESS Newswire
Study Links Autism to Increased Risk of Developing Parkinson’s Disease
Via Investor Brand Network
Researchers Discover Potential Missing Connection Between EBV and Multiple Sclerosis
Via Investor Brand Network
Eye Exam Could Help in Detecting Parkinson’s Disease Early, Study Suggests
Via Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Reports Q1 Results, Advances CNM-Au8 Toward Potential Accelerated Approval for ALS
Via Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Participate in D. Boral Capital Global Conference on May 14
Via Investor Brand Network
Scientists ID Bacteria That Could Be Behind Multiple Sclerosis Development
Via Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Reports Evidence of Remyelination, Cognitive and Visual Gains in MS Trial
Via Investor Brand Network
Study Suggests Possible Link Between ADHD and Heightened Dementia Risk
Via Investor Brand Network
Clene Inc. (NASDAQ: CLNN) to Share CNM-Au8(R) Progress at Jones Las Vegas Conference
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.